Invention Grant
- Patent Title: Engineered CRISPR-Cas9 nucleases with altered PAM specificity
-
Application No.: US17456092Application Date: 2021-11-22
-
Publication No.: US11859220B2Publication Date: 2024-01-02
- Inventor: J. Keith Joung , Benjamin Kleinstiver
- Applicant: The General Hospital Corporation
- Applicant Address: US MA Boston
- Assignee: The General Hospital Corporation
- Current Assignee: The General Hospital Corporation
- Current Assignee Address: US MA Boston
- Agency: Fish & Richardson P.C.
- The original application number of the division: US15935334 2018.03.26
- Main IPC: C12N9/22
- IPC: C12N9/22 ; C12N15/10 ; C12N15/11 ; C12N15/90 ; A61K38/00 ; C12N15/63
Abstract:
Engineered CRISPR-Cas9 nucleases with altered and improved PAM specificities and their use in genomic engineering, epigenomic engineering, and genome targeting.
Public/Granted literature
- US20230021303A9 Engineered CRISPR-Cas9 nucleases with Altered PAM Specificity Public/Granted day:2023-01-19
Information query
